Publications by authors named "Yannick Verhoeven"

Claim this Profile
T
Targeting hedgehog signaling in pancreatic ductal adenocarcinoma.
Delphine Quatannens, Yannick Verhoeven, Peter Van Dam, Filip Lardon, Hans Prenen

Pharmacol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunologic aspects in hormone receptor positive breast cancer.
Gizem Oner, Sevilay Altintas, Zafer Canturk, Wiebren Tjalma, Christophe Van Berckelaer, Yannick Verhoeven

Cancer Treat Res Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-PET Molecular Imaging of RANKL in Cancer.
Jonatan Dewulf, Christel Vangestel, Yannick Verhoeven, Jorrit De Waele, Karen Zwaenepoel

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update.
Yannick Verhoeven, Delphine Quatannens, Xuan Bich Trinh, An Wouters, Evelien L J Smits

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer.
Andreas Domen, Delphine Quatannens, Sara Zanivan, Christophe Deben, Jonas Van Audenaerde, Yannick Verhoeven

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Non-Bone-Related Role of RANK/RANKL Signaling in Cancer.
Peter A van Dam, Yannick Verhoeven, Xuan B Trinh

Adv Exp Med Biol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-negative breast cancer-Role of immunology: A systemic review.
Gizem Oner, Sevilay Altintas, Zafer Canturk, Wiebren Tjalma, Yannick Verhoeven

Breast J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential and controversy of targeting STAT family members in cancer.
Yannick Verhoeven, Sam Tilborghs, Julie Jacobs, Jorrit De Waele, Delphine Quatannens

Semin Cancer Biol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone metastases in the era of targeted treatments: insights from molecular biology.
Jonatan Dewulf, Christel Vangestel, Yannick Verhoeven, Peter van Dam, Filipe Elvas

Q J Nucl Med Mol Imaging· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.
Peter A van Dam, Yannick Verhoeven, Julie Jacobs, An Wouters, Wiebren Tjalma

Int J Mol Sci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment.
Peter A van Dam, Yannick Verhoeven, Xuan B Trinh, An Wouters, Filip Lardon

Crit Rev Oncol Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Nuclear Factor-kappa B signaling in human cervical cancer.
Sam Tilborghs, Jerome Corthouts, Yannick Verhoeven, David Arias, Christian Rolfo

Crit Rev Oncol Hematol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis